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A B S T R A C T   
Introduction and importance: Friedreich’s Ataxia is an autosomal recessive disease and is usually associated with 
arterial dysfunction, muscle weakness, spasm in the lower extremities, scoliosis, bladder dysfunction, lack of 
reflexes in the lower extremities, and imbalance. Approximately 2.3 people have cardiomyopathy. In this article, 
we have reviewed a case of Friedreich’s Ataxia with hypertrophic cardiomyopathy. 
Case presentation: A 19-year-old woman with Friedreich’s Ataxia has been protesting since she was 11 years old 
and complained of chest pains, dyspnea, and heart palpitations without a medical history. In ECG, Asymmetrical 
invert T wave diffuse, diffuse ST-segment depression, and left ventricular hypertrophy were observed. In 
echocardiography, the left ventricle was reported as hyperimmobile with increased EF (70–75%). 
Clinical discussion: In the present study, a patient with Friedrich Ataxia was diagnosed with chest pain, dyspnea, 
and palpitations without any medical history, and was discharged from the hospital after treatment. In the 
patients introduced and our patient, there was significant fibro-myocardial hypertrophy, in which the ventricular 
septal hypertrophy was marked by hypertrophic cardiomyopathy. 
Conclusion: Because early diagnosis of the disease is difficult, clinical signs and the patient’s current profile at the 
time of referral will be very helpful.   
1. Introduction 
Ataxia Friedrich (FRDA) is the most common autosomal recessive 
spinocerebellar ataxia [1] that occurs due to the development of trinu-
cleotide in the frataxin gene on chromosome 9 [2]. Clinical manifesta-
tions include ataxia in the limbs and trunk, arterial dysfunction, lack of 
deep tendon reflexes, sensory disturbances, skeletal deformity, diabetes, 
and cardiac involvement [3]. This protein is mitochondrial and is 
involved in iron homeostasis and respiratory function [4]. Ataxia Frie-
drich, with a prevalence of 1 in 50,000 people, is the most common 
inherited degenerative disease of the nervous system and is less common 
in South Africa, Asia, and the Americas [5]. Neurological symptoms 
begin before puberty and before the age of 25. The need for a wheelchair 
is essential for the progression of neuromuscular dysfunction within 
10–20 years after the onset of symptoms, and in most cases, neurological 
symptoms occur before cardiac symptoms. Ataxia-Friedrich’s cardio-
vascular symptoms are less common with concentric hypertrophic 
cardiomyopathy and with less symmetrical septal hypertrophy. The 
presence of left ventricular outflow gradient with septal hypertrophy has 
also been reported. At the same time, dilated cardiomyopathy can occur, 
which is rare, and dilated cardiomyopathy is caused by the progression 
of hypertrophic cardiomyopathy. 95% of neurological patients have 
electrocardiographic and echocardiographic disorders. Wide reverse T 
wave is common in all leads. About 10% of patients with left ventricular 
systolic dysfunction have an ejection deficit of less than 50% (1). Severe 
dilated cardiomyopathy with progressive heart failure can occur [6]. 
Arrhythmias are less common in Ataxia Friedrich than in high-grade 
arrhythmias in hypertrophy. Atrial arrhythmias, including fibrillation 
and fluttering, are associated with progression to dilated cardiomyop-
athy. Ventricular tachycardia has been reported in dilated cardiomy-
opathy. Sudden death has been reported but the mechanism is not well 
established [7]. Idebenone slightly reduces left ventricular mass and 
hypertrophy, improves left ventricular systolic function, and has no 
neurological consequences. Cardiac death occurs in patients with dilated 
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cardiomyopathy. Heart failure is the most common cause of death [8]. 
Complex arrhythmias are responsible for 1.3 mortality due to heart 
failure in patients. The role of pharmacotherapy or defibrillator therapy 
in ataxia-Friedrich and dilated cardiomyopathy has not been evaluated, 
but should be considered as long as treatment for the disease is available 
[9]. In this article, we have reviewed a case of Friedrich Ataxia with 
hypertrophic cardiomyopathy. 
2. Patient introduction 
A 19-year-old woman with Friedrich Ataxia, who has been protesting 
since she was 11, had gone to the emergency room with a complaint of 
chest pain, dyspnea, and heart palpitations without any previous med-
ical history. He mentioned the background of Friedrich Ataxia in his 
brother and two of his cousins. The vital signs at the onset of high blood 
pressure were 120/80, heart rate 120, respiration rate 16, oral body 
temperature: 36.6 c, and SPO2: 95%. 
The patient was checked by a cardiologist with 10 years’ experience. 
Troponin tests were negative and other tests were normal. Robotic 
speech physical examination included arterial dystrophy, gait distur-
bance, and relative wheelchair dependence. Heart rate S1 and S2 were 
heard in the cardiac hearing and in the LSB, holosystolic 4.6 was heard. 
Friction rub was not heard. Lung hearing was normal. In the ECG taken 
from the patient, incomplete RBBB, J point elevation, Asymmetrical 
invert T wave diffuse, ST-segment depression diffuse, and according to 
Cornell and Estes + Romhilt criteria, left ventricular hypertrophy was 
observed (R III> 20mm + SV3 + R avl> 29mm). In the CXR, the apex is 
rounded and rises above the diaphragm level, and the sclerosis is quite 
obvious. Echocardiography showed left ventricular hyperplasia with 
elevated EF (70–75%), No LVOT obstruction, mild MR, mild TR, severe 
LVH, increased septal thickness unrelated to HOCM, which was even-
tually diagnosed with HCM. On complete neurological examination, the 
reflexes of the Patellar, Achilles, Plantar flexor decreased, and the 
Romberg test was positive. Magnetic resonance imaging also showed 
scoliosis of the spine by rotation of the lumbar vertebrae and disc pro-
trusion. In EMG, the performance potential of the sensory nerves was 
severely reduced, indicating severe polyneuropathy. She was 
hospitalized for sinus tachycardia and was eventually discharged with 
beta-blockers (25 mg twice a day) (Figs. 1–3). The present work has been 
reported in line with the SCARE 2020 criteria [10]: 
3. Discussion 
FRDA is the most common type of inherited ataxia and accounts for 
approximately 50% of all inherited ataxias [11]. It is a slow, progressive 
disease in which, according to the FRDA, 15 years after the first symp-
toms appear, the patient becomes sedentary and the symptoms worsen 
day by day, and the average age of loss is 3/37 years [12]. Pathological 
changes in the heart are known in Friedrich Ataxia and were studied by 
Sanchez et al., In 1976. In most cases, death is due to heart failure and 
cardiomyopathy. Over the past few years, a large number of hypertro-
phic cardiomyopathies have been clinically diagnosed in patients with 
Friedrich Ataxia. Some authors have suggested that hypertrophic car-
diomyopathy may be specific to Friedrich Ataxia [13]. Due to the rarity 
of the disease, the number of articles that reported people with the 
disease was limited. In one case, an 18-year-old Caucasian girl was 
diagnosed with Friedrich Ataxia, who first showed signs of her illness at 
the age of two. Two of the family’s eight children as siblings got infected. 
She was in a wheelchair at the age of 10. At the age of 6, she was 
diagnosed with left ventricular hypertrophy on her electrocardiogram. 
Both right and left ventricular diastolic pressures increased to 16 and 22 
mm Hg, respectively. In the next years, she complained of palpitations 
that had never been documented by the E.C.G., and the patient also had 
no history of shortness of breath or chest pain. One month before his 
death, he had BP: 65/600 and HR: 80. Lung hearing was okay, and there 
was no murmur or galloping rhythm in his heart sounds. Chest X-rays 
showed no evidence of cardiomyopathy or high pulmonary hyperten-
sion, but radiographs showed right posterior scoliosis. The electrocar-
diogram showed scattered changes in the ST and T parts with suspicion 
of right ventricular hypertrophy and deviation of the right axis. Also, in 
echocardiography, the systolic and diastolic diameters of the left 
ventricle were 20 and 30, respectively, and the thickness of the septum 
and posterior wall was normal. Two days before her death, the patient 
experienced nausea and vomiting of blood, and progressive and 
Fig. 1. ECGs after entering to hospital emergency ward.  
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prolonged apnea led to her death. In the following, we will introduce a 
case of a 22-year-old Caucasian man suffering from Friedreich’s Ataxia. 
Two Venetian sisters and brothers had the same disease, the eldest of 
whom died at the age of 25. The patient has been dependent on a 
wheelchair since he was 12 years old. He was recently admitted to the 
hospital with a fever of over 100◦ Fahrenheit and a cough. Two days 
later, the cough and fever continued, and he also experienced a lot of 
nausea and vomiting. Two days later, the patient became lethargic and 
pale, had a decreased level of consciousness, and tachycardia. On ex-
amination of the cardiovascular condition, HR: 150–180 and irregular, 
systolic, and jugular veins were non-dilated. The deformed thorax and 
scoliosis of the back were evident in him. In the ECG taken from the 
patient, atrial fibrillation with a ventricular velocity of 230 beats per 
minute was observed with right branch block and severe right axis de-
viation. The patient died of a continuous shock a few hours after being 
hospitalized [14]. In the present study, a patient with Friedrich Ataxia 
was diagnosed with chest pain, dyspnea, and palpitations without any 
medical history, and was discharged from the hospital after treatment. 
In the patients introduced and our patient, there was significant 
fibro-myocardial hypertrophy, in which the ventricular septal hyper-
trophy was marked by hypertrophic cardiomyopathy. 
4. Conclusion 
Because it is difficult to early diagnose the disease, it can be very 
helpful to pay attention to the patient’s clinical symptoms and current 
condition at the time of referral. 
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